Home
Home

Regeneron

Novartis to Shire Said to Weigh Bids for ThromboGenics

Novartis to Shire Said to Weigh Bids for ThromboGenics
Bloomberg

Biotechs Struggling To Find A Bottom

Biotechs Struggling To Find A Bottom
Yahoo/Benzinga

Study: New Cholesterol Drugs Effectively Lower LDL Levels

Study: New Cholesterol Drugs Effectively Lower LDL Levels
Wall St Cheat Sheet

New Cholesterol Fighters To Take Center Stage At ACC

New Cholesterol Fighters To Take Center Stage At ACC
Investors.com

JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again

JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's

FDA Concerns Are the Least of These Drugs' Worries

FDA Concerns Are the Least of These Drugs' Worries
Motley Fool

Health-Care Stocks: Growing Like Gangbusters

Health-Care Stocks: Growing Like Gangbusters
Motley Fool

With FDA Concerns Public, What's Next for These Cholesterol Drugs?

With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool

FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade

FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes

FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks

FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters